NCT06892860 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06892860
Title	Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer (DISCUS)
Acronym	DISCUS
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Queen Mary University of London
Indications	bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma urethra transitional cell carcinoma
Therapies	Avelumab Cisplatin + Gemcitabine Carboplatin + Gemcitabine
Age Groups:	adult \| senior
Covered Countries	GBR \| FRA \| ESP

Facility	Status	City	Country	Details
Unicancer	RECRUITING	Paris	France	Details
Adknoma	ENROLLING_BY_INVITATION	Madrid	Spain	Details
Barts Health NHS Trust	RECRUITING	London	United Kingdom	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06892860Clinical Trial Detail